Shenzhen Feng Beiru Life Engineering Co., Ltd.

PRODUCT

Cell therapy engineering Immunotherapy engineering Tissue and Organ Engineering Blood transfusion therapy Organ transplantation treatment Reproduction engineering Exosome Engineering

Immunotherapy engineering - Others

Human CD19+ B Cell Isolation Kit (Primary Selection)

Product Code：F-020401010

Product Usage：Suitable for the rapid and straightforward isolation of highly purified CD19+ B cells from fresh or cryopreserved peripheral blood mononuclear cells.

Patent Number

Patent Number：

Application Scenarios

This product is intended for research or further study purposes only and is not intended for diagnosis or treatment.

Product Overview

This product enables the rapid and straightforward isolation of highly purified CD19+ B cells from fresh or cryopreserved peripheral blood mononuclear cells. It can process a total cell volume of 1x10^9 cells, yielding over 90% CD19+ B cells post-purification. This provides a robust tool for utilizing CD19+ B cells in both basic and clinical research.

We are a high-tech enterprise specializing in the latest life medical technologies such as frontier life sciences and cell engineering therapy, immune engineering therapy, tissue engineering therapy, and organ transplantation therapy. We integrate R&D, production, sales and technical services, and are committed to providing global research institutions, medical institutions and biopharmaceutical enterprises with comprehensive and high-quality products and solutions in cell technology, immune technology, and tissue organ technology.

Hotline

Hotline: 0752-2228195
E-mail
Company address: 10th Floor, Building 3, Zone A, Xihu Zhigu, Shuikou Street, Huicheng District, Huizhou City

: Official WeChat

Message

Guangdong ICP License No. 2025504308-1

Technical Support: Shenyang Cloud Technology